News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Scientists trying to curb malaria deaths usually concentrate on preventing mosquito bites or developing human vaccines and therapies, but novel gene-editing tool CRISPR is opening up another path.
Brazilian company Eurofarma claims it has developed Latin America’s first home-grown biosimilar.
Abzena is set to buy The Chemistry Research Solution (TCRS) in a deal one analyst says shows the firm’s intentions to dominate the bio-conjugation space.
The EMA has given the thumbs up to Benepali, a biosimilar of Amgen’s Enbrel developed by Samsung Bioepis, a JV between Biogen and Samsung Biologics.